Mounjaro Coupons and Savings (2026 Guide)
Every active Mounjaro discount, compared side by side. All savings apply only to FDA-approved use (type 2 diabetes). Updated monthly.
The lowest Mounjaro out-of-pocket price in 2026 is $25 per month via the Mounjaro Savings Card for patients with commercial insurance that covers Mounjaro for type 2 diabetes. Patients with commercial insurance whose plan does not cover Mounjaro pay as low as $499 per month with the same card. Federal insurance plans (Medicare, Medicaid, Tricare, VA, DOD) are excluded from the Savings Card by law. The PAN Foundation offers copay assistance for income-qualified insured patients. Mounjaro does not have a cash-pay program for uninsured patients; retail pricing remains $995 to $1,294 per month. Patients seeking tirzepatide for weight loss should use Zepbound, which has a $299 to $449 per month cash-pay path through LillyDirect.
Looking for tirzepatide for weight loss? Use Zepbound, not Mounjaro.
Mounjaro and Zepbound contain the same active ingredient (tirzepatide) at the same doses. The difference is FDA approval: Mounjaro is approved for type 2 diabetes, Zepbound is approved for weight loss. Insurance rarely covers Mounjaro for off-label weight loss, forcing patients to pay $995+ per month retail. Zepbound offers a LillyDirect Self Pay program at $299-$449/month, which Mounjaro does not. If your goal is weight loss, talk to your prescriber about Zepbound instead.
Active Mounjaro savings in 2026
Three programs covering commercial insurance and nonprofit copay assistance. Prices verified this month against Lilly's published pages.
Which Mounjaro savings program fits you?
Mounjaro is FDA-approved for type 2 diabetes. For weight loss, consider Zepbound (same medication, different label).
Medicare Part D may cover Mounjaro for diabetes with prior authorization; check your specific plan. Medicaid coverage varies by state. Cannot use Mounjaro Savings Card. Expect $10-$50/month copays if covered. MFN framework may expand access mid-2026.
Mounjaro is not FDA-approved for weight loss; insurance almost never covers off-label use. Mounjaro has no cash-pay discount program. Your best path is Zepbound (same drug, approved for weight loss) at $299-$449/month via LillyDirect Self Pay.
Uninsured patients cannot use the Mounjaro Savings Card (card requires commercial insurance). Retail prices range $995-$1,294/month even with discount cards (GoodRx, SingleCare). For weight loss, use Zepbound LillyDirect Self Pay at $299-$449/month. For diabetes, consider cheaper alternatives like metformin or discuss other options with your prescriber.
A note on compounded tirzepatide
FDA declared the tirzepatide shortage resolved in late 2024. As of 2025-2026, pharmacies are no longer permitted to regularly compound tirzepatide injections. Narrow exceptions exist for documented patient-specific medical needs.
Beware of counterfeit tirzepatide or providers claiming to offer compounded tirzepatide without documented patient-specific medical need.
For weight loss, use Zepbound LillyDirect Self Pay ($299-$449/month). Compounded tirzepatide is no longer a reliable routine option.
Frequently asked questions
Questions patients ask most often about Mounjaro coupons, coverage, and the weight-loss distinction.
Same drug. FDA-approved for weight loss. Cheaper cash-pay.
Zepbound contains the same tirzepatide as Mounjaro at the same doses, but Eli Lilly offers a LillyDirect Self Pay program for Zepbound at $299 to $449 per month. Mounjaro does not have an equivalent cash-pay path.
Pricing verified against Eli Lilly's official pricinginfo.lilly.com and mounjaro.lilly.com pages, cross-referenced with GoodRx, Noom, Drugs.com, and AARP reporting. We do not accept payment for inclusion in any comparison. Medical content reviewed by Dr. Golsa Gholampour, MD, board-certified in obesity medicine. Quarterly re-verification scheduled.